Summary

The genu recurvatum market was valued at $6.5 billion in 2023, and is projected to reach $11.2 billion by 2033, growing at a CAGR of 5.6% from 2024 to 2033.
Genu recurvatum is a medical condition characterized by hyperextension of the knee joint, leading to an abnormal backward curvature while standing or walking. This condition can be caused by a variety of factors, including congenital anomalies, neuromuscular disorders, ligamentous laxity, or trauma. Genu recurvatum can range from mild to severe and often affects joint stability, gait mechanics, and overall mobility. Depending on its severity and underlying cause, it may be associated with discomfort, a higher risk of knee injuries, or long-term joint degeneration if left untreated.

The global genu recurvatum market is witnessing robust growth due to factors such as alarming rise in prevalence of neuromuscular disorders such as cerebral palsy, muscular dystrophy, and post-stroke complications, which increase the incidence of genu recurvatum, and surge in demand for therapeutic and corrective solutions. A 2022 study published by National Institutes of Health (NIH)—one of the world's foremost medical research centers—revealed that on an average the prevalence of individuals who inherited neuromuscular disorders is 3.7–4.99 per 10,000. In addition, rise in awareness of knee-related deformities and their long-term impact on mobility and quality of life has boosted early diagnosis and treatment adoption. Furthermore, increase in incidence of knee injuries due to sports, accidents, and other trauma has propelled the demand for rehabilitative therapies, including solutions for secondary conditions like genu recurvatum. Moreover, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that older adults are more susceptible to joint laxity and degenerative conditions, increasing the need for both conservative and surgical interventions for genu recurvatum. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. However, lack of awareness and delayed diagnosis significantly restrains the market growth. Genu recurvatum often remains underdiagnosed, especially in milder cases or in underserved regions, due to a lack of awareness among patients and healthcare providers. Furthermore, high cost associated with surgical procedures, custom orthotics, and advanced rehabilitation technologies hampers the market growth. On the contrary, innovations in knee braces, prosthetics, and assistive devices tailored to manage genu recurvatum have expanded treatment options, improving patient outcomes. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.

The global genu recurvatum market is segmented into treatment type, end user, and region. On the basis of treatment type, the market is categorized into human surgical treatments and non-surgical treatments. Further, the surgical treatments segment is divided into osteotomy, arthroscopy, and knee realignment surgeries. The non-surgical treatments segment is subsegmented into physical therapy, bracing & orthotics, and rehabilitation exercises. Depending on end user, it is categorized into hospitals, orthopedic clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings
By treatment type, the non-surgical treatments segment is expected to dominate the market from 2024 to 2033.
On the basis of end user, orthopedic clinics segment is anticipated to exhibit the highest growth during the forecast period.
Region wise, the genu recurvatum market is likely to witness strong growth in North America.
Competition Analysis
Competitive analysis and profiles of the major players in the global genu recurvatum market include Medtronic Plc, Stryker Corporation, Smith & Nephew Plc, Johnson and Johnson (DePuy Synthes), Zimmer Biomet Holdings, Inc., Globus Medical Inc, Össur, aspen medical products, and Thuasne Group, Breg, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.


Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Regulatory Guidelines
● Expanded list for Company Profiles
● Historic market data
● Reimbursement Scenario
Key Market Segments
By Treatment Type
● Surgical Treatments
○ Osteotomy
○ Arthroscopy
○ Knee Realignment Surgeries
● Non-Surgical Treatments
○ Physical Therapy
○ Bracing and Orthotics
○ Rehabilitation Exercises
By End User
● Hospitals
● Orthopedic Clinics
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ France
○ Germany
○ Italy
○ Spain
○ UK
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ Rest of LAMEA
● Key Market Players
○ medtronic PLc
○ Stryker Corporation
○ Smith & Nephew plc
○ Johnson and Johnson (DePuy Synthes)
○ Zimmer Biomet Holdings, Inc.
○ Globus Medical Inc
○ Össur
○ aspen medical products
○ Thuasne Group
○ Breg, Inc

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: GENU RECURVATUM MARKET, BY TREATMENT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Treatment Type
4.2. Surgical Treatments
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Osteotomy
4.2.5.1. Market Size and Forecast
4.2.6. Arthroscopy
4.2.6.1. Market Size and Forecast
4.2.7. Knee Realignment Surgeries
4.2.7.1. Market Size and Forecast
4.3. Non-Surgical Treatments
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Physical Therapy
4.3.5.1. Market Size and Forecast
4.3.6. Bracing and Orthotics
4.3.6.1. Market Size and Forecast
4.3.7. Rehabilitation Exercises
4.3.7.1. Market Size and Forecast
CHAPTER 5: GENU RECURVATUM MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Orthopedic Clinics
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: GENU RECURVATUM MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Treatment Type
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Genu Recurvatum Market
6.2.5.1. Market Size and Forecast, By Treatment Type
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Genu Recurvatum Market
6.2.6.1. Market Size and Forecast, By Treatment Type
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Genu Recurvatum Market
6.2.7.1. Market Size and Forecast, By Treatment Type
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Treatment Type
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. France Genu Recurvatum Market
6.3.5.1. Market Size and Forecast, By Treatment Type
6.3.5.2. Market Size and Forecast, By End User
6.3.6. Germany Genu Recurvatum Market
6.3.6.1. Market Size and Forecast, By Treatment Type
6.3.6.2. Market Size and Forecast, By End User
6.3.7. Italy Genu Recurvatum Market
6.3.7.1. Market Size and Forecast, By Treatment Type
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Spain Genu Recurvatum Market
6.3.8.1. Market Size and Forecast, By Treatment Type
6.3.8.2. Market Size and Forecast, By End User
6.3.9. UK Genu Recurvatum Market
6.3.9.1. Market Size and Forecast, By Treatment Type
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Genu Recurvatum Market
6.3.10.1. Market Size and Forecast, By Treatment Type
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Treatment Type
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. China Genu Recurvatum Market
6.4.5.1. Market Size and Forecast, By Treatment Type
6.4.5.2. Market Size and Forecast, By End User
6.4.6. Japan Genu Recurvatum Market
6.4.6.1. Market Size and Forecast, By Treatment Type
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Genu Recurvatum Market
6.4.7.1. Market Size and Forecast, By Treatment Type
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Genu Recurvatum Market
6.4.8.1. Market Size and Forecast, By Treatment Type
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Genu Recurvatum Market
6.4.9.1. Market Size and Forecast, By Treatment Type
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Genu Recurvatum Market
6.4.10.1. Market Size and Forecast, By Treatment Type
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Treatment Type
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Genu Recurvatum Market
6.5.5.1. Market Size and Forecast, By Treatment Type
6.5.5.2. Market Size and Forecast, By End User
6.5.6. South Africa Genu Recurvatum Market
6.5.6.1. Market Size and Forecast, By Treatment Type
6.5.6.2. Market Size and Forecast, By End User
6.5.7. Saudi Arabia Genu Recurvatum Market
6.5.7.1. Market Size and Forecast, By Treatment Type
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Genu Recurvatum Market
6.5.8.1. Market Size and Forecast, By Treatment Type
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Medtronic PLc
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Stryker Corporation
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Smith And Nephew Plc
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Johnson And Johnson (DePuy Synthes)
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Zimmer Biomet Holdings, Inc.
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Globus Medical Inc
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Össur
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Aspen Medical Products
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Thuasne Group
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Breg, Inc
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments